Locomotor Training for Wounds
Phase-Based Progress Estimates
Effectiveness
Safety
Wounds+20 More
Locomotor Training - BehavioralEligibility
18+
Male
What conditions do you have?
Select
Eligibility
18+
Male
What conditions do you have?
Select
Study Summary
This trial will study the feasibility of using testosterone replacement therapy along with locomotor training to improve walking function in men with spinal cord injuries and low testosterone levels.
Eligible Conditions
- Wounds
- Testosterone Deficiency
- Spinal Cord Injuries
- Spinal Cord Diseases
- Duck Gait
- Gonadal Disorders
- Androgen Deficiency
- Hypogonadism
- Walking, Difficulty
- Axonotmesis
- Spinal Cord
- Trauma, Spinal Cord
- Genital Diseases, Male
- Nervous System Diseases
- Endocrine System Diseases
- Gait Disorders, Neurologic
- Hormone Deficiency
- Central Nervous System Diseases
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: baseline, 1 month, 3 months, 6 months
Month 6
change in 10m walk test (10mWT)
change in 6 min walk test (6MWT)
Month 6
change in bone formation marker
change in bone resorption marker
change in distal femur bone mineral density
change in knee extensor peak torque
change in thigh muscle cross-sectional area
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Trial Design
3 Treatment Groups
non-interventional control
1 of 3
testosterone enanthate
1 of 3
locomotor training, testosterone enanthate
1 of 3
Active Control
Experimental Treatment
21 Total Participants · 3 Treatment Groups
Primary Treatment: Locomotor Training · No Placebo Group · Phase 2
testosterone enanthate
Drug
Experimental Group · 1 Intervention: Testosterone Enanthate · Intervention Types: Druglocomotor training, testosterone enanthateExperimental Group · 2 Interventions: Locomotor Training, Testosterone Enanthate · Intervention Types: Behavioral, Drug
non-interventional controlNoIntervention Group · 1 Intervention: non-interventional control · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Locomotor Training
2013
Completed Phase 1
~110
Testosterone enanthate
FDA approved
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 1 month, 3 months, 6 months
Who is running the clinical trial?
Brooks RehabilitationOTHER
11 Previous Clinical Trials
1,956 Total Patients Enrolled
University of FloridaOTHER
1,235 Previous Clinical Trials
696,964 Total Patients Enrolled
North Florida/South Georgia Veterans Health SystemOTHER
7 Previous Clinical Trials
1,964 Total Patients Enrolled
North Florida Foundation for Research and EducationLead Sponsor
13 Previous Clinical Trials
752 Total Patients Enrolled
Joshua F Yarrow, PhDPrincipal InvestigatorNorth Florida/South Georgia Veterans Health System
Eligibility Criteria
Age 18+ · Male Participants · 9 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have a diagnosis of an incomplete SCI involving spinal segments L1 or above or a clinically complete SCI involving spinal segments T2-L1, with upper motor neuron injury signs (i.e.
You are willing to take TRT as instructed by the study staff and to abide by study protocol.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments